Literature DB >> 10530873

Functional properties of Ca2+-inhibitable type 5 and type 6 adenylyl cyclases and role of Ca2+ increase in the inhibition of intracellular cAMP content.

D Chabardès1, M Imbert-Teboul, J M Elalouf.   

Abstract

Among the different adenylyl cyclase (AC) isoforms, type 5 and type 6 constitute a subfamily which has the remarkable property of being inhibited by submicromolar Ca2+ concentrations in addition to Galphai-mediated processes. These independent and cumulative negative regulations are associated to a low basal enzymatic activity which can be strongly activated by Galphas-mediated interactions or forskolin. These properties ensure possible wide changes of cAMP synthesis. Regulation of cAMP synthesis by Ca2+ was studied in cultured or native cells which express naturally type 5 and/or type 6 AC, including well-defined renal epithelial cells. The results underline two characteristics of the inhibition due to agonist-elicited increase of intracellular Ca2+: i) Ca2+ rises achieved through capacitive Ca2+ entry or intracellular Ca2+ release can inhibit AC to a similar extent; and ii) in a same cell type, different agonists inducing similar overall Ca2+ rises elicit a variable inhibition of AC activity. The results suggest that a high efficiency of AC regulation by Ca2+ is linked to a requisite close localization of AC enzyme and Ca2+ rises.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10530873     DOI: 10.1016/s0898-6568(99)00031-5

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  18 in total

1.  Impaired D2 dopamine receptor function in mice lacking type 5 adenylyl cyclase.

Authors:  Ko-Woon Lee; Jang-Hee Hong; In Young Choi; Yongzhe Che; Ja-Kyeong Lee; Sung-Don Yang; Chang-Woo Song; Ho Sung Kang; Jae-Heun Lee; Jai Sung Noh; Hee-Sup Shin; Pyung-Lim Han
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

2.  Stimulation of renin secretion by catecholamines is dependent on adenylyl cyclases 5 and 6.

Authors:  Fadi Aldehni; Tong Tang; Kirsten Madsen; Michael Plattner; Andrea Schreiber; Ulla G Friis; H Kirk Hammond; Pyung Lim Han; Frank Schweda
Journal:  Hypertension       Date:  2011-01-31       Impact factor: 10.190

Review 3.  Potential pharmacological interventions in polycystic kidney disease.

Authors:  Amirali Masoumi; Berenice Reed-Gitomer; Catherine Kelleher; Robert W Schrier
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 4.  Regulation and organization of adenylyl cyclases and cAMP.

Authors:  Dermot M F Cooper
Journal:  Biochem J       Date:  2003-11-01       Impact factor: 3.857

5.  Activator of G protein signaling 3 promotes epithelial cell proliferation in PKD.

Authors:  Rama Nadella; Joe B Blumer; Guangfu Jia; Michelle Kwon; Talha Akbulut; Feng Qian; Filip Sedlic; Tetsuro Wakatsuki; William E Sweeney; Patricia D Wilson; Stephen M Lanier; Frank Park
Journal:  J Am Soc Nephrol       Date:  2010-05-20       Impact factor: 10.121

6.  Vasopressin and hydration play a major role in the development of glucose intolerance and hepatic steatosis in obese rats.

Authors:  Christopher Taveau; Catherine Chollet; Ludovic Waeckel; Dorinne Desposito; Daniel G Bichet; Marie-Françoise Arthus; Christophe Magnan; Erwann Philippe; Valerie Paradis; Fabienne Foufelle; Isabelle Hainault; Sofia Enhorning; Gilberto Velho; Ronan Roussel; Lise Bankir; Olle Melander; Nadine Bouby
Journal:  Diabetologia       Date:  2015-01-27       Impact factor: 10.122

7.  Loss of activator of G-protein signaling 3 impairs renal tubular regeneration following acute kidney injury in rodents.

Authors:  Kevin R Regner; Kandai Nozu; Stephen M Lanier; Joe B Blumer; Ellis D Avner; William E Sweeney; Frank Park
Journal:  FASEB J       Date:  2011-02-22       Impact factor: 5.191

8.  Stimulation of renin secretion by angiotensin II blockade is Gsalpha-dependent.

Authors:  Limeng Chen; Soo Mi Kim; Christoph Eisner; Mona Oppermann; Yuning Huang; Diane Mizel; Lingli Li; Min Chen; Maria Luisa Sequeira Lopez; Lee S Weinstein; Roberto A Gomez; Jurgen Schnermann; Josephine P Briggs
Journal:  J Am Soc Nephrol       Date:  2010-04-15       Impact factor: 10.121

9.  Primary cilium-dependent mechanosensing is mediated by adenylyl cyclase 6 and cyclic AMP in bone cells.

Authors:  Ronald Y Kwon; Sara Temiyasathit; Padmaja Tummala; Clarence C Quah; Christopher R Jacobs
Journal:  FASEB J       Date:  2010-04-06       Impact factor: 5.191

10.  Tolvaptan plus pasireotide shows enhanced efficacy in a PKD1 model.

Authors:  Katharina Hopp; Cynthia J Hommerding; Xiaofang Wang; Hong Ye; Peter C Harris; Vicente E Torres
Journal:  J Am Soc Nephrol       Date:  2014-07-03       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.